Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Medtronic (NY: MDT )

88.58 +0.39 (+0.44%)
Official Closing Price Updated: 7:00 PM EDT, Aug 30, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 7,940,129
Open 88.33
Bid (Size) 86.30 (1)
Ask (Size) 88.77 (2)
Prev. Close 88.19
Today's Range 87.23 - 88.60
52wk Range 68.84 - 90.13
Shares Outstanding N/A
Dividend Yield 3.12%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
This Is Great News for Medtronic, but Is It Time to Buy the Stock?
This MedTech leader is back on track with profitable growth. 
Via The Motley Fool
Stock Market Rallies As Powell Confirms Rate Cuts; Palo Alto, Cava, Target Jump: Weekly Review
Palo Alto and Cava were among the earnings winners. 
Via Investor's Business Daily

Performance

YTD
+6.93%
+6.93%
1 Month
+10.05%
+10.05%
3 Month
+7.87%
+7.87%
6 Month
+4.14%
+4.14%
1 Year
+7.85%
+7.85%

More News

Read More
Diabetes and Neuro Products Ignite Medtronic’s Q1 Earnings Rally
Via MarketBeat
Exposures Product Safety
Medtronic Analysts Boost Their Forecasts After Upbeat Earnings
Via Benzinga
Key Takeaways From Medtronic Analyst Ratings
Via Benzinga
Looking Into Medtronic's Recent Short Interest
Via Benzinga
Texas Instruments To Rally Around 16%? Here Are 10 Top Analyst Forecasts For Wednesday
Via Benzinga
Medtronic (MDT) Q1 2025 Earnings Call Transcript
Via The Motley Fool
Topics Earnings
Exposures Financial
Wall Street Eases, Bonds Rises, US Dollar Falls To 8-Month Low: What's Driving Markets Tuesday?
Via Benzinga
Nasdaq Moves Lower; Medtronic Posts Upbeat Earnings
Via Benzinga
MDT Stock Earnings: Medtronic Beats EPS, Beats Revenue for Q1 2025
Via InvestorPlace
Medical Devices Giant Medtronic Q1 Earnings: Revenue And EPS Beat, Lifts Annual Guidance Marginally On Sustained Growth From New Product Launches
Via Benzinga
Medtronic Posts Modest Beat-And-Raise Report For Fiscal First Quarter
Via Investor's Business Daily
US Stocks May Take a Breather After S&P 500's Impressive 8-Session Winning Streak: Strategist Says Market Will Hit Fresh Highs In Next 4 Weeks, But Warns Investors Of Potential Risks
Via Benzinga
Topics Stocks
Exposures US Equities
S&P 500, Nasdaq Extend Gains For 8th Consecutive Session: Investor Sentiment Improves, But Greed Index Remains In 'Fear' Zone
Via Benzinga
Topics Stocks
Exposures US Equities
Lowe's, Palo Alto Networks And 3 Stocks To Watch Heading Into Tuesday
Via Benzinga
5 Dividend Growth Stocks to Buy and Hold Forever
Via The Motley Fool
3 Dividend Stocks to Double Up On Right Now
Via The Motley Fool
Robinhood To Rally Around 29%? Here Are 10 Top Analyst Forecasts For Thursday
Via Benzinga
7 Defensive Stocks to Buy as Investors Seek Shelter
Via InvestorPlace
TJX To Rally Over 15%? Here Are 10 Top Analyst Forecasts For Wednesday
Via Benzinga
Is PROCEPT BioRobotics the Next Big Thing in Surgical Robotics?
Via MarketBeat
Abbott Laboratories Stock Could Soar to $143, According to a Wall Street Analyst. Is It a Buy Around $108?
Via The Motley Fool
Orchestra BioMed Reports Second Quarter 2024 Financial Results and Provides a Business Update
From Orchestra BioMed Holdings, Inc.
Via GlobeNewswire
Chips, Glorious Chips!
Via The Motley Fool
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.